GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $506 | -14.5% | 17,058 | +3.2% | 0.00% | -20.0% |
| Q2 2023 | $592 | +24.1% | 16,537 | -18.7% | 0.01% | +25.0% |
| Q1 2023 | $477 | -22.1% | 20,348 | -9.6% | 0.00% | -20.0% |
| Q4 2022 | $612 | -99.9% | 22,498 | +1.5% | 0.01% | -58.3% |
| Q3 2022 | $1,193,000 | +35.7% | 22,164 | +1.8% | 0.01% | +50.0% |
| Q2 2022 | $879,000 | -36.4% | 21,779 | +4.3% | 0.01% | -27.3% |
| Q1 2022 | $1,383,000 | -63.6% | 20,872 | -45.0% | 0.01% | -21.4% |
| Q4 2021 | $3,796,000 | +86.7% | 37,950 | +133.4% | 0.01% | -17.6% |
| Q3 2021 | $2,033,000 | -5.1% | 16,261 | -5.7% | 0.02% | 0.0% |
| Q2 2021 | $2,143,000 | -7.7% | 17,252 | +13.5% | 0.02% | -80.5% |
| Q1 2021 | $2,321,000 | +8.5% | 15,202 | -8.4% | 0.09% | +7.4% |
| Q4 2020 | $2,139,000 | +26.0% | 16,600 | +9.3% | 0.08% | +9.5% |
| Q3 2020 | $1,698,000 | +35.8% | 15,189 | -1.4% | 0.07% | +27.6% |
| Q2 2020 | $1,250,000 | +86.3% | 15,407 | +59.9% | 0.06% | +262.5% |
| Q1 2020 | $671,000 | -12.2% | 9,634 | -1.5% | 0.02% | +14.3% |
| Q4 2019 | $764,000 | +37.4% | 9,780 | +12.3% | 0.01% | +16.7% |
| Q3 2019 | $556,000 | -15.1% | 8,706 | +14.8% | 0.01% | -20.0% |
| Q2 2019 | $655,000 | – | 7,585 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |